Founded in 2011 and located in Hangzhou Future Science and Technology City, MicroTech Medical is a pioneer in the diabetes management medical device industry, innovating and integrating diabetes treatment and monitoring, reshaping the diabetes management paradigm in China and globally. Designated a Key Diabetes Research Center in Zhejiang Province, China, MicroTech Medical has established a research and development center in Silicon Valley.

MicroTech Medical boasts a strong in-house R&D team of nearly 100 employees. Over 30% of these R&D staff hold master’s or doctoral degrees and have extensive R&D experience at leading medical device companies.

MicroTech Medical is committed to innovation in diabetes management and strives to bring healthcare products to the global market. The company’s product portfolio includes therapeutic products such as the Equil Patch insulin pump and diagnostics such as the AiDEX continuous glucose monitoring system (CGMS), multi-line glucose monitoring system (BGMS), and point-of-care (POCT) products.

With this broad product portfolio, MicroTech Medical continues to provide greater freedom, flexibility, and choice for those limited by diabetes.